Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
Germany’s Affimed N.V. announced a pair of immuno-oncology collaborations in the past week with Roivant Sciences and








